Depo-subQ provera 104 Approval History
- FDA approved: Yes (First approved December 17th, 2004)
- Brand name: depo-subQ provera 104
- Generic name: medroxyprogesterone acetate
- Company: Pfizer Inc.
- Treatment for: Birth Control
depo-subQ provera 104 (medroxyprogesterone acetate) is a lower dose, subcutaneous formulation of Depo Provera indicated for the prevention of pregnancy in women of child bearing potential.
Development History and FDA Approval Process for depo-subQ provera 104
|Dec 17, 2004||depo-subQ provera 104 Pfizer Inc. - Treatment for Prevention of Pregnancy|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.